Marek Sanak Selected Research

Marek Sanak Research Topics

Disease

58	Asthma (Bronchial Asthma) 09/2023 - 01/2003
26	Hypersensitivity (Allergy) 03/2023 - 04/2004
20	Inflammation (Inflammations) 06/2023 - 04/2013
13	Aspirin-Induced Asthma 10/2022 - 05/2003
10	COVID-19 06/2023 - 01/2020
9	Eosinophilia 11/2023 - 01/2011
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 03/2009
8	Urticaria (Hives) 01/2019 - 04/2004
7	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 02/2012
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 12/2005
6	Infections 01/2023 - 08/2014
6	Rhinosinusitis 01/2019 - 03/2006
5	Angioedema 01/2019 - 04/2004
4	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 06/2017
4	Coronary Disease (Coronary Heart Disease) 11/2020 - 03/2010
4	Myocardial Infarction 11/2020 - 01/2016
3	Neoplasms (Cancer) 12/2023 - 01/2018
3	Choroidal Neovascularization 03/2021 - 02/2012
3	Metaplasia 01/2021 - 10/2013
3	Hemorrhage 11/2019 - 09/2010
3	Nasal Polyps (Nasal Polyp) 01/2019 - 01/2016
3	Anaphylaxis (Anaphylactic Shock) 01/2019 - 05/2013
3	Atherosclerosis 01/2018 - 03/2010
3	Hearing Loss (Hearing Impairment) 10/2015 - 04/2000
3	Lung Diseases (Lung Disease) 01/2012 - 01/2004
2	Systemic Scleroderma (Systemic Sclerosis) 12/2023 - 08/2023
2	Virus Diseases (Viral Diseases) 01/2022 - 03/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022 - 05/2013
2	Central Serous Chorioretinopathy 10/2021 - 03/2021
2	Necrosis 03/2021 - 01/2018
2	Hypertension (High Blood Pressure) 03/2021 - 02/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2005
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2011
2	Thrombosis (Thrombus) 11/2020 - 02/2014
2	Disease Progression 01/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

31	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023 - 05/2003
18	EicosanoidsIBA 01/2022 - 01/2004
17	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2013
11	ProstaglandinsIBA 01/2021 - 05/2003
10	MicroRNAs (MicroRNA)IBA 06/2023 - 10/2015
10	LeukotrienesIBA 01/2022 - 10/2010
10	Dinoprostone (PGE2)FDA Link 01/2021 - 05/2003
9	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2022 - 04/2004
8	CytokinesIBA 12/2023 - 01/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 02/2012
8	Prostaglandin D2IBA 03/2023 - 04/2013
8	Immunoglobulin E (IgE)IBA 01/2022 - 11/2006
7	AntibodiesIBA 01/2022 - 02/2012
6	Antiviral Agents (Antivirals)IBA 06/2023 - 09/2012
6	LipidsIBA 01/2023 - 01/2013
6	Leukotriene E4IBA 01/2021 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
6	SteroidsIBA 01/2020 - 03/2006
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 03/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 10/2014
4	Interleukin-8 (Interleukin 8)IBA 08/2023 - 01/2019
4	InterferonsIBA 01/2023 - 09/2012
4	Arachidonic Acid (Vitamin F)IBA 01/2019 - 03/2006
4	Retinaldehyde (Retinal)IBA 01/2016 - 02/2012
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2006 - 05/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2023 - 01/2012
3	Complement System Proteins (Complement)IBA 05/2022 - 01/2015
3	Interleukin-4 (Interleukin 4)IBA 03/2021 - 10/2012
3	ThromboxanesIBA 01/2021 - 01/2016
3	AcidsIBA 01/2021 - 10/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2016
3	ChemokinesIBA 01/2019 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 08/2014
3	Bevacizumab (Avastin)FDA Link 11/2016 - 02/2012
2	Interleukin-17 (Interleukin 17)IBA 12/2023 - 11/2019
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2023 - 08/2014
2	InflammasomesIBA 06/2023 - 01/2023
2	Antiphospholipid AntibodiesIBA 01/2023 - 02/2014
2	Anticardiolipin AntibodiesIBA 01/2023 - 02/2014
2	factor V LeidenIBA 01/2023 - 11/2020
2	AllergensIBA 01/2023 - 01/2017
2	Prothrombin (Factor II)IBA 01/2023 - 01/2007
2	Thrombin FDA Link 01/2023 - 01/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 01/2005
2	InterleukinsIBA 03/2021 - 09/2012
2	Interleukin-5 (Interleukin 5)IBA 03/2021 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 03/2021 - 11/2019
2	Interleukin-10 (Interleukin 10)IBA 03/2021 - 10/2012
2	IsoprostanesIBA 01/2021 - 09/2015
2	Particulate MatterIBA 01/2021 - 07/2014
2	5-oxo-eicosatetraenoic acidIBA 01/2021 - 01/2020
2	11-dehydro-thromboxane B2IBA 01/2021 - 01/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2020 - 01/2019
2	Cocaine (Cocaine HCl)IBA 07/2020 - 01/2019
2	Leukotriene B4IBA 01/2020 - 01/2019
2	Interleukin-13IBA 11/2019 - 10/2013
2	Leukotriene C4IBA 01/2019 - 04/2013
2	ProteomeIBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 11/2018 - 01/2003
2	EnzymesIBA 01/2018 - 01/2004
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 01/2005
2	Immunoglobulin G (IgG)IBA 12/2016 - 02/2014

Therapy/Procedure

12	Therapeutics 05/2022 - 01/2012
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 09/2010
2	Secondary Prevention 01/2018 - 01/2007